NDC 59212-200
Uroxatral
Alfuzosin Hcl
Uroxatral is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Concordia Pharmaceuticals Inc.. The primary component is Alfuzosin Hydrochloride.
| Product ID | 59212-200_2f119319-ba14-4824-a2dd-5e01f737674a |
| NDC | 59212-200 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Uroxatral |
| Generic Name | Alfuzosin Hcl |
| Dosage Form | Tablet, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2013-06-03 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021287 |
| Labeler Name | Concordia Pharmaceuticals Inc. |
| Substance Name | ALFUZOSIN HYDROCHLORIDE |
| Active Ingredient Strength | 10 mg/1 |
| Pharm Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
Packaging
NDC 59212-200-10
100 TABLET, EXTENDED RELEASE in 1 BOTTLE (59212-200-10)
| Marketing Start Date | 2013-06-03 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 59212-200-20 [59212020020]
Uroxatral TABLET, EXTENDED RELEASE
| Marketing Category | NDA |
| Application Number | NDA021287 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2013-06-03 |
| Marketing End Date | 2019-01-31 |
NDC 59212-200-10 [59212020010]
Uroxatral TABLET, EXTENDED RELEASE
| Marketing Category | NDA |
| Application Number | NDA021287 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2013-06-03 |
NDC 59212-200-30 [59212020030]
Uroxatral TABLET, EXTENDED RELEASE
| Marketing Category | NDA |
| Application Number | NDA021287 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-01-18 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| ALFUZOSIN HYDROCHLORIDE | 10 mg/1 |
OpenFDA Data
| SPL SET ID: | 9fc7f119-f36b-44cf-945d-940160f3afe3 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
Pharmacological Class
- Adrenergic alpha-Antagonists [MoA]
- alpha-Adrenergic Blocker [EPC]
Medicade Reported Pricing
59212020010 UROXATRAL 10 MG TABLET
Pricing Unit: EA | Drug Type:
Trademark Results [Uroxatral]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 UROXATRAL 76233890 2679884 Live/Registered |
Concordia Pharmaceuticals Inc. 2001-03-28 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.